NCCN Publishes Comprehensive Stage-Specific Breast Cancer Resources for Patients
New NCCN Guidelines for Patients®: Breast Cancer Stages 0 – IV now available free-of-charge at NCCN.org/patients; NCCN Guidelines for Patients® are educational resources that offer patient-friendly treatment information.
Article ID: 617388
Released: 5-May-2014 10:30 AM EDT
Source Newsroom: National Comprehensive Cancer Network® (NCCN®)
Newswise — FORT WASHINGTON, PA — The National Comprehensive Cancer Network® (NCCN®), with the support of the NCCN Foundation®, announces the availability of the NCCN Guidelines for Patients®: Breast Cancer Stages 0 – IV—the latest addition to the library of NCCN Guidelines for Patients® available online free-of-charge at NCCN.org/patients. This is the first comprehensive stage-specific library of NCCN Guidelines for Patients published by NCCN.
The NCCN Guidelines for Patients, patient-friendly translations of the NCCN Clinical Practice Guidelines on Oncology (NCCN Guidelines®), are designed to provide state-of-the-art treatment information in easy-to-understand language to people with cancer and their caregivers.
NCCN Guidelines for Patients®: Breast Cancer was originally published in 2010; NCCN Guidelines for Patients®: Stage 0 Breast Cancer—the first stage-specific installment of NCCN Guidelines for Patients—was made available in November 2013.
“NCCN is pleased to be able to offer patients and their caregivers a trusted, comprehensive, and concise educational resource for breast cancer treatment,” said Robert W. Carlson, MD, Chief Executive Officer, NCCN. “Given the incredible amount of information that is publicly available about breast cancer, the stage-specific NCCN Guidelines for Patients: Breast Cancer offer patients a more personalized approach to their disease, empowering them to make well-informed decisions about their treatment.”
The NCCN Guidelines® are developed by multidisciplinary panels of experts from NCCN Member Institutions and feature sequential decision algorithms that address appropriate management options from initial work-up through the course of the disease. The NCCN Guidelines for Patients translate the professional guidelines into a clear, step-by-step format that people can use as the basis for making decisions and discussing treatment options with their physicians.
In addition to the patient resources available for breast cancer, NCCN currently offers NCCN Guidelines for Patients for the following: Colon, Esophageal, Non-Small Cell Lung, Ovarian, Pancreatic, and Prostate Cancers; Caring for Adolescents and Young Adults (AYA); Chronic Myelogenous Leukemia; Malignant Pleural Mesothelioma; Melanoma; Multiple Myeloma; and Lung Cancer Screening. NCCN Guidelines for Patients are made possible by charitable donations to the NCCN Foundation. Print versions are available for certain disease types as supplies last.
Visit NCCN.org/patients for the library of NCCN Guidelines for Patients, as well as other patient and caregiver resources.
About the National Comprehensive Cancer NetworkThe National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 25 of the world’s leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers.
The NCCN Member Institutions are: Fred and Pamela Buffett Cancer Center at The Nebraska Medical Center, Omaha, NE; City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ, Jacksonville, FL, and Rochester, MN; Memorial Sloan-Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UC San Diego Moores Cancer Center, La Jolla, CA; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Colorado Cancer Center, Aurora, CO; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; The University of Texas MD Anderson Cancer Center, Houston, TX; Vanderbilt-Ingram Cancer Center, Nashville, TN; and Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT.